Northern Trust’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-136,117
| Closed | -$17.9M | – | 4542 |
|
|
2020
Q4 | $17.9M | Sell |
136,117
-2,543
| -2% | -$335K | ﹤0.01% | 1862 |
|
|
2020
Q3 | $7.01M | Buy |
138,660
+2,640
| +2% | +$133K | ﹤0.01% | 2323 |
|
|
2020
Q2 | $6.48M | Sell |
136,020
-4,665
| -3% | -$222K | ﹤0.01% | 2360 |
|
|
2020
Q1 | $6.89M | Buy |
140,685
+750
| +0.5% | +$36.7K | ﹤0.01% | 2120 |
|
|
2019
Q4 | $8.03M | Sell |
139,935
-3,618
| -3% | -$208K | ﹤0.01% | 2321 |
|
|
2019
Q3 | $5.16M | Sell |
143,553
-40,562
| -22% | -$1.46M | ﹤0.01% | 2535 |
|
|
2019
Q2 | $5.72M | Buy |
184,115
+2,647
| +1% | +$82.3K | ﹤0.01% | 2491 |
|
|
2019
Q1 | $4.26M | Buy |
181,468
+86,867
| +92% | +$2.04M | ﹤0.01% | 2650 |
|
|
2018
Q4 | $1.3M | Buy |
94,601
+4,594
| +5% | +$63.2K | ﹤0.01% | 3263 |
|
|
2018
Q3 | $898K | Buy |
90,007
+76,182
| +551% | +$760K | ﹤0.01% | 3498 |
|
|
2018
Q2 | $281K | Buy |
+13,825
| New | +$281K | ﹤0.01% | 3749 |
|